Contribute Try STAT+ Today

Rise and shine, another busy day is on the way. Despite the challenging environment outside your window, the world keeps spinning, after all. So time to embrace the possibilities. Please join us as we reach for another cup of stimulation — maple bourbon is our choice today — and get ready to tackle the ever-growing to-do list. We hope you conquer the world today and, as always, do keep in touch. We appreciate your thoughts and tips. Meanwhile, stay safe — and wear a mask. …

Infuriated by FDA defiance in a showdown over the Trump administration standards for authorizing a Covid-19 vaccine, Department of Health and Human Services Secretary Alex Azar has spent recent weeks openly plotting the ouster of FDA Commissioner Stephen Hahn, Politico reports. The intrigue comes amid deep frustration with Hahn over his insistence that a vaccine meet stricter safety standards, a contentious decision that rendered it impossible for President Trump to fulfill his desire for a vaccine authorization just before Election Day.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy